about
Breastfeeding as a Protective Effect Against Childhood Leukemia and LymphomaInsulin-like Growth Factor-1 (IGF-1): Demographic, Clinical and Laboratory Data in 120 Consecutive Adult Patients with Thalassaemia MajorClinical and laboratory patterns of the haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in southern Iran.Genetic characterization of patients with Bernard-Soulier syndrome and their relatives from Southern Iran.ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpura.Termination of pregnancy due to Thalassemia major, Hemophilia, and Down's syndrome: the views of Iranian physiciansMagnetic resonance imaging to determine the incidence of brain ischaemia in patients with beta-thalassaemia intermedia.Cerebral thrombosis in patients with β-thalassemia: a systematic review.Frequency of cholelithiasis in patients with Beta-thalassemia intermedia with and without hydroxyurea.Cerebral infarction in β-thalassemia intermedia: breaking the silence.Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13).The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in IranHydroxyurea Treatment in Transfusion-Dependent β-Thalassemia PatientsComparative study of radiographic and laboratory findings between Beta thalassemia major and Beta thalassemia intermedia patients with and without treatment by hydroxyureaSerum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia.Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern IranEvaluation of bone mineral density in patients with hemoglobin H disease.Is red cell from an otherwise healthy G6PD-deficient donor efficient for transfusion to fauvism patients?The Diagnostic Approach to Central Adrenocortical Insufficiency (CAI) in Thalassemia.Transcranial Doppler Ultrasonography in Beta-thalassemia Major Patients Without and With ThrombocytosisDDAVP Might Reduce the Risk of Preeclampsia in Pregnant Women with VWF Deficiency.Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran.Management of Bleeding in Post-liver Disease, Surgery and Biopsy in Patients With High Uncorrected International Normalized Ratio With Prothrombin Complex Concentrate: An Iranian Experience.Inherited thrombophilia and recurrent pregnancy loss.Hydroxyurea in the management of thalassemia intermedia.β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint.Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in Iran.Contemporary approaches to treatment of beta-thalassemia intermedia.Spectrum of the mutations in Bernard-Soulier syndrome.Guidelines for diagnosis and management of Beta-thalassemia intermedia.Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran.Safety and effectiveness of room temperature stable recombinant factor VIIa in patients with haemophilia A or B and inhibitors: Results of a multinational, prospective, observational study.Evaluation of red cell membrane cytoskeletal disorders using a flow cytometric method in South iran.A comparison of heart function and arrhythmia in clinically asymptomatic patients with beta thalassemia intermedia and beta thalassemia major.The ICET-A Survey on Current Criteria Used by Clinicians for the Assessment of Central Adrenal Insufficiency in Thalassemia: Analysis of Results and Recommendations.Thyroid function and stress hormones in children with stress hyperglycemia.Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.The effect of metoprolol succinate on the cardiac function of patients with thalassaemia cardiomyopathy: a double-blind randomised study.Intracranial Blood Flow Velocity in Patients with β-Thalassemia Intermedia Using Transcranial Doppler Sonography: A Case-Control Study.
P50
Q28818624-644C023A-1240-4B27-A716-44C032EC12E1Q30870542-69B67989-A672-4302-B35A-B272C3506C83Q33372486-D3B689F1-848A-4C1A-9F84-52319A612B35Q33376464-CC77C14C-2C0F-4CBC-ABD1-200A4DB15E19Q33378424-6BE70415-65D5-4C43-B7BA-71C16E9E607BQ33382602-A12138C5-3456-42C0-9BEB-AEDBD5E761EAQ33395484-08384B8C-775F-4C0A-BCDA-E2F9130EBB5DQ33533386-6011069E-E809-4BA7-892F-D39123C0A371Q34155589-02193C1A-7B4E-4188-87B6-E6EF08C56973Q34197393-54858340-194A-4745-93C8-7EF67846B501Q34363046-F99D060E-A96D-4115-9BC2-5076A5E80A32Q34801914-574E6E93-9FEA-48AC-945F-7229E290148FQ34822017-DF0C3B49-0A19-4B33-9A92-5BE7FD5904E7Q35213992-2846DD54-4319-4AA5-98C3-2372F838B9BCQ35225524-43AEEA44-63BA-4CB3-95AD-445368C973C2Q35644563-FAB038DD-361F-4CA8-9131-75829ACD2DABQ35793024-D90171E2-5EE0-4FBA-A207-D2AE371A852BQ36038928-E89DF30D-8599-410E-B682-ECAC363F0EDDQ36263930-8C6919A6-6072-4E47-A9D6-B9323328263AQ36844407-0EC327CA-E974-4549-B558-73D4689EFED7Q37100695-ECCF48CB-A243-44E7-923B-79B685EB6080Q37426422-9380C3D6-38E0-4352-8014-50246A125F27Q37522170-7B7C88B4-BB88-4995-85E2-01D1982F8E3BQ37639517-0D926D5D-C914-4BDD-97FA-DBD2709E53A3Q37639529-6B65B7D6-A31D-46BD-9B58-E8A7C0B12150Q37650445-C6ACC40F-25FB-44C8-9D34-A4548AFF41A5Q37677224-D00BAFB4-D173-4B17-9FEA-D2AC29EF06F4Q37966812-F09E1B83-5321-4ACB-8D16-4BBC5209B783Q38013167-032F7877-D9A1-4DC7-983A-59AE60AAFE4AQ38220681-586032CD-78CA-4F45-B30C-8582383496DDQ38253432-96BD28F0-0853-435E-A06F-DDFB31A10F7FQ38662673-5BD5BB46-636C-4E90-ABA4-DE1313224846Q38821467-C37CE5E4-85CF-4663-BAC0-2AA2F1B7469EQ38914499-2347AF7C-8990-4AD8-B09E-658D53ABADE1Q39369214-32C360AB-0EF5-414F-B752-7C97B8BD9462Q39603538-7D944D74-E9E4-4E93-9E1E-3CB23F175C87Q39609307-C2256235-BA86-482E-9CFB-05C0520CC3B0Q39659820-989140B8-E8E1-49D5-9815-5E96CEF6B8AEQ40209714-0E6D6C14-8F9B-4DB4-B39A-4E20CCA3120DQ40253377-4E6F391C-73F6-405C-8C80-95832C48BECD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mehran Karimi
@ast
Mehran Karimi
@en
Mehran Karimi
@es
Mehran Karimi
@nl
type
label
Mehran Karimi
@ast
Mehran Karimi
@en
Mehran Karimi
@es
Mehran Karimi
@nl
prefLabel
Mehran Karimi
@ast
Mehran Karimi
@en
Mehran Karimi
@es
Mehran Karimi
@nl
P106
P1153
56472931600
P31
P496
0000-0001-8555-1001